CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
批准号:
2091961
负责人:
MICHAEL B LILLY
金额:
$10.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1998-08-15
关键词:
antisense nucleic acid apoptosis biological signal transduction colony stimulating factor cytokine gene expression hematopoietic growth factor myelogenous leukemia neoplasm /cancer immunology phenotype plasmids polymerase chain reaction recombinant proteins tissue /cell culture transfection western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from applicant's abstract)This application seeks
to characterize critical steps in the proliferative signalling pathways
activated by GM-CSF in related cytokines in primitive myeloid cells. At
least some cases of myeloid leukemia likely result from over activity
of such signal pathways. Identification of critical or unique steps in
such cascades may allow development of pharmacologic interventions to
specifically disrupt these pathways. The specific hypothesis of this
application is that expression of the pim-1 gene project, a 33 kd
serine/threonine kinase, is necessary for effective proliferative
signalling through GM-CSF and related receptors. The applicant further
hypothesizes that pim-1 expression serves as a specific indicator of
activation of such pathways. The hypothesis will be investigated by
constructing cell systems which allow for the over expression or blockade
of pim-1 activity. Factor-dependent myeloid cell lines will be
transfected with plasmid constructs or retroviral constructs to allow
autonomous expression of the pim-1 gene product.These lines will then
be examined for factor- independent growth, impaired differentiation,
inhibition of apoptosis and homotypic aggregation. Similar cell lines
will be created utilizing plasmids containing antisense pim-1 constructs
to inhibit activity of the endogenous pim-1 gene. These cells will be
studied for the responsiveness to GM-CSF and related cytokines and their
propensity to differentiation.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sodium vanadate, a tyrosine phosphatase inhibitor, affects expression of hematopoietic growth factors and extracellular matrix RNAs in SV40-transformed human marrow stromal cells.
钒酸钠是一种酪氨酸磷酸酶抑制剂,可影响 SV40 转化的人骨髓基质细胞中造血生长因子和细胞外基质 RNA 的表达。
DOI:
--
发表时间:
1992
期刊:
Experimental hematology
影响因子:
2.6
作者:
[Andrews3rd,DF, Lilly,MB, Tompkins,CK, Singer,JW]
通讯作者:
Singer,JW
Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells.
白介素6和粒细胞巨噬细胞集落刺激因子是慢性粒单核细胞白血病细胞的候选生长因子。
DOI:
--
发表时间:
1989
期刊:
Blood
影响因子:
20.3
作者:
[Everson,MP, Brown,CB, Lilly,MB]
通讯作者:
Lilly,MB
Effect of granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8 production by human neutrophils and monocytes.
粒细胞-巨噬细胞集落刺激因子和白细胞介素 3 对人中性粒细胞和单核细胞产生白细胞介素 8 的影响。
DOI:
--
发表时间:
1993
期刊:
Blood
影响因子:
20.3
作者:
[Takahashi,GW, Andrews3rd,DF, Lilly,MB, Singer,JW, Alderson,MR]
通讯作者:
Alderson,MR
Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
与粒细胞巨噬细胞集落刺激因子融合的白喉毒素对幼年型粒单核细胞白血病和慢性粒单核细胞白血病患者的原始细胞具有毒性。
DOI:
--
发表时间:
1998
期刊:
Blood
影响因子:
20.3
作者:
[Frankel,AE, Lilly,M, Kreitman,R, Hogge,D, Beran,M, Freedman,MH, Emanuel,PD, McLain,C, Hall,P, Tagge,E, Berger,M, Eaves,C]
通讯作者:
Eaves,C
AN ANTIBODY THAT INHIBITS IN VITRO BONE MARROW PROLIFERATION IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND APLASTIC ANEMIA
一种抑制系统性红斑狼疮和再生障碍性贫血患者体外骨髓增殖的抗体
DOI:
10.1002/j.2326-5205.1989.tb00022.x
发表时间:
1989
期刊:
Arthritis & Rheumatology
影响因子:
13.3
作者:
[F. Amos Bailey, Michael Lilly, L. Bertoli, G. V. Ball]
通讯作者:
G. V. Ball
共 8 条
Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
-
批准号:8723134
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
-
批准号:8512436
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:9242567
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MUSC/HCC Paul Calabresi Clinical Oncology Training Program Plan
-
批准号:8831452
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2013
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:7391006
-
项目类别:
-
资助金额:$3.09万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:6783914
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
MOLECULAR TARGETS OF ANTI-TUMOR NSAIDS
-
批准号:6892356
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2004
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188842
-
项目类别:
-
资助金额:$4.21万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
-
批准号:2091960
-
项目类别:
-
资助金额:$9.47万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALING IN MYELOID LEUKEMIAS
-
批准号:2091959
-
项目类别:
-
资助金额:$10.19万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188844
-
项目类别:
-
资助金额:$8.8万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
CYTOKINE SIGNALLING IN MYELOID LEUKEMIAS
-
批准号:3509555
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188843
-
项目类别:
-
资助金额:$12.65万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
THERAPEUTIC USES FOR HUMAN GRANULOCYTE CSF
-
批准号:3188839
-
项目类别:
-
资助金额:$14.11万
-
财政年份:1987
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177712
-
项目类别:
-
资助金额:$10.89万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177711
-
项目类别:
-
资助金额:$10.13万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
ASSESSMENT OF HYPERTHERMIA BY IN VIVO NMR SPECTROSCOPY
-
批准号:3177710
-
项目类别:
-
资助金额:$10.39万
-
财政年份:1984
-
负责人:MICHAEL B LILLY
-
依托单位:
Murine model of chronic prostatitis
-
批准号:7547700
-
项目类别:
-
资助金额:$1.56万
-
财政年份:--
-
负责人:MICHAEL B LILLY
-
依托单位:
A Phase 1b Trial of Oligomeric Procyanidin Complex in Combination with Metformin for Reduced AGE Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
-
批准号:9419085
-
项目类别:
-
资助金额:$7.45万
-
财政年份:--
-
负责人:MICHAEL B LILLY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: